Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
Open Access
- 1 August 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (8), 1501-1508
- https://doi.org/10.1038/mt.2010.94
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Immune Responses to AAV in Canine Muscle Monitored by Cellular Assays and Noninvasive ImagingMolecular Therapy, 2010
- Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imagingMuscle & Nerve, 2009
- Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyBlood, 2009
- A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in DogsMolecular Therapy, 2008
- Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx MiceMolecular Therapy, 2008
- Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of ImmunosuppressionMolecular Therapy, 2007
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Blood, 2004
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null MutationMolecular Therapy, 2001
- Increased Serum Alanine Aminotransferase Activity Associated With Muscle Necrosis in the DogJournal of Veterinary Internal Medicine, 1990